November 10, 2026
Elite Diagnostic Limited (ELITE) has advised that further to its notice dated October 30, 2026, regarding the Take-Over Offer by Resource Assets Limited for all of the Company’s issued ordinary shares (the Offer), its Directors’ Circular in response to the Offer will be published and sent to shareholders on or before Tuesday November 17, 2026. ELITE has further advised that the Directors’ Circular could not be issued within the period prescribed by the Regulations for two reasons:
- the valuation of certain specialised equipment owned by the Company requires a specialist valuator and could not be completed in time; and
- the independent financial adviser’s opinion, which takes account of that valuation, is being finalised.
ELITE has also advised that the Offer is currently scheduled to close on November 30, 2026.
For further details, visit www.jamstockex.com
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
